These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10355337)

  • 1. [Interactions and adverse drug reactions: how to obtain information].
    Fattinger KE
    Praxis (Bern 1994); 1999 Apr; 88(16):713-8. PubMed ID: 10355337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The incidence of drug side effects with reference to organ systems. Experience of the spontaneous reporting system of the Swiss Drug Side Effect Center and Comprehensive Drug Monitoring].
    Kuhn M; Hartmann K; Maibach R; Capaul R; Gartmann JC
    Ther Umsch; 1993 Jan; 50(1):8-12. PubMed ID: 8378869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
    Blenkinsopp A; Wilkie P; Wang M; Routledge PA
    Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spontaneous reporting system for the assessment of new, unknown and rare undesirable effects of drugs].
    Hartmann K; Kuhn M; Gartmann J
    Schweiz Med Wochenschr; 1992 Sep; 122(38):1409-13. PubMed ID: 1411399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric adverse drug reaction reporting: understanding and future directions.
    Carleton BC; Smith MA; Gelin MN; Heathcote SC
    Can J Clin Pharmacol; 2007; 14(1):e45-57. PubMed ID: 17297195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
    Mey C; Hentschel H; Hippius M; Balogh A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adverse drug reactions definitions and terminology].
    Rabinovitz H; Berkowitch M; Golik A; Shani S
    Harefuah; 2001 Dec; 140(12):1181-6, 1228. PubMed ID: 11789305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions in a south Indian hospital--their severity and cost involved.
    Ramesh M; Pandit J; Parthasarathi G
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):687-92. PubMed ID: 14762985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient reporting of adverse drug reactions: useful information for pain management?
    Jarernsiripornkul N; Krska J; Richards RM; Capps PA
    Eur J Pain; 2003; 7(3):219-24. PubMed ID: 12725844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
    Fleuranceau-Morel P
    Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance: characteristics of the most widely used drugs in Bulgaria.
    Getov I; Dimitrova Z
    Cent Eur J Public Health; 1999 Aug; 7(3):133-6. PubMed ID: 10499144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of adverse drug reactions: from diagnosis to signal.
    Edwards IR
    Therapie; 2001; 56(6):727-33. PubMed ID: 11878098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Under-reporting of serious adverse drug reactions in Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective study of adverse drug reactions in the elderly: experience of regional center for pharmacovigilance].
    Bruneau S; Bruhat C; Lagarce L; Lainé-Cessac P
    Therapie; 2001; 56(6):785-91. PubMed ID: 11878111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adverse internal medicine drug effects at hospital admission].
    Lepori V; Perren A; Marone C
    Schweiz Med Wochenschr; 1999 Jun; 129(24):915-22. PubMed ID: 10413826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and evaluation of adverse drug effects].
    Thürmann PA; Schmitt K
    Med Klin (Munich); 2000 May; 95(1 Spec No):4-8. PubMed ID: 10851841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing adverse drug reactions in the general population.
    Pezalla E
    Manag Care Interface; 2005 Oct; 18(10):49-52. PubMed ID: 16265935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug side effects as the probable cause of death. Results of the Berne Comprehensive Hospital Drug Monitoring Program].
    Zoppi M; Török M; Stoller-Güleryüz D; Winzenried P; Marty H; Hess T; Stucki P; Bickel MH; Stocker F; Hoigné R
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1808-10. PubMed ID: 7178881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.